OpenLegislation

Regulation 5 Fee for scientific advice: classification of a medicinal product

Original text. Later amendments are not shown.

(1)

The fee payable by a person with whom the licensing authority holds a meeting to provide scientific advice in connection with the classification of a relevant medicinal product, is—

(a)

£2,986, if the advice relates to a product which, if reclassified, will be available on general sale; and

(b)

£3,917, if the advice relates to a product which, if reclassified, will be available without a prescription from a pharmacy.

(2)

For the purposes of this regulation, a product is on general sale if it is a medicinal product of a description or falling within a class specified in an Order made under section 51 (general sale lists) of the Actf1.

Annotations

Footnotes

f1

Amendments have been made to section 51 by S.I. 2006/2407.